MITOZOLOMIDE (NSC-353451), A NEW ACTIVE-DRUG IN THE TREATMENT OF MALIGNANT-MELANOMA - PHASE-II TRIAL IN PATIENTS WITH ADVANCED DISEASE

被引：12

作者：

GUNDERSEN, S

AAMDAL, S

FODSTAD, O

机构：

[1] NORWEGIAN RADIUM HOSP,DEPT BIOCHEM,N-0310 OSLO 3,NORWAY

[2] NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT TUMOR BIOL,N-0310 OSLO 3,NORWAY

来源：

关键词：

D O I：

10.1038/bjc.1987.85

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：433 / 435

页数：3

共 7 条

[1] FODSTAD O, 1985, CANCER RES, V45, P1778
[2] GIBSON NW, 1984, CANCER RES, V44, P1772
[3] HICKMAN JA, 1985, CANCER RES, V45, P3008
[4] MAGNUS K, 1981, CANCER, V48, P2329, DOI 10.1002/1097-0142(19811115)48:10<2329::AID-CNCR2820481032>3.0.CO
[5] 2-O
[6] NEWLANDS ES, 1985, CANCER TREAT REP, V69, P801
[7] ANTITUMOR IMIDAZOTETRAZINES .1. SYNTHESIS AND CHEMISTRY OF 8-CARBAMOYL-3-(2-CHLOROETHYL)IMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE, A NOVEL BROAD-SPECTRUM ANTITUMOR AGENT
STEVENS, MFG
HICKMAN, JA
STONE, R
GIBSON, NW
BAIG, GU
LUNT, E
NEWTON, CG
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (02) : 196 - 201